206 related articles for article (PubMed ID: 12054798)
1. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
[TBL] [Abstract][Full Text] [Related]
2. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
[TBL] [Abstract][Full Text] [Related]
3. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
4. X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a peptide from the group A streptococcal surface protein PAM.
Cnudde SE; Prorok M; Castellino FJ; Geiger JH
Biochemistry; 2006 Sep; 45(37):11052-60. PubMed ID: 16964966
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: existence of novel and expected binding modes.
Mikol V; LoGrasso PV; Boettcher BR
J Mol Biol; 1996 Mar; 256(4):751-61. PubMed ID: 8642595
[TBL] [Abstract][Full Text] [Related]
8. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
9. Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4.
Mulichak AM; Tulinsky A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):673-9. PubMed ID: 1966798
[TBL] [Abstract][Full Text] [Related]
10. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
11. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
12. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
[TBL] [Abstract][Full Text] [Related]
13. Crystallization and preliminary X-ray diffraction studies of human angiostatin.
Abad MC; Geiger J
Acta Crystallogr D Biol Crystallogr; 2002 Mar; 58(Pt 3):513-4. PubMed ID: 11856839
[TBL] [Abstract][Full Text] [Related]
14. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
[TBL] [Abstract][Full Text] [Related]
15. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.
Lu H; Dhanabal M; Volk R; Waterman MJ; Ramchandran R; Knebelmann B; Segal M; Sukhatme VP
Biochem Biophys Res Commun; 1999 May; 258(3):668-73. PubMed ID: 10329443
[TBL] [Abstract][Full Text] [Related]
16. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of action of angiostatin: can you teach an old dog new tricks?
Moser TL; Stack MS; Wahl ML; Pizzo SV
Thromb Haemost; 2002 Mar; 87(3):394-401. PubMed ID: 11916069
[TBL] [Abstract][Full Text] [Related]
18. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
[TBL] [Abstract][Full Text] [Related]
19. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.
Chang Y; Mochalkin I; McCance SG; Cheng B; Tulinsky A; Castellino FJ
Biochemistry; 1998 Mar; 37(10):3258-71. PubMed ID: 9521645
[TBL] [Abstract][Full Text] [Related]
20. Angiostatin and angiostatin-related proteins.
Soff GA
Cancer Metastasis Rev; 2000; 19(1-2):97-107. PubMed ID: 11191071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
